TLR4 and colitis: Similarly, a number of compounds with functional foods properties have been described to act as TLR4 ligands or activators having no deleterious effect in vivo (such as colitis) while limiting experimental intestinal inflammation, including bovine glycomacropeptide, nonabsorbable carbohydrates or active hexose correlated compound [33,44,45,46,47,48,49,50,51,52].